Dr. Madhukar Pai, Associate Director of the McGill International TB Centre and Director of McGill Global Health Programs, compared the fight against tuberculosis to that against HIV/AIDS in a recent op-ed appearing on IBN Live. In the piece, Dr. Pai, discusses the need to consider offering ‘Universal Drug Susceptibility Testing (DST)’ across the country, to all patients with TB, to ensure that they receive accurate treatment, based on drug-resistance information. He argues it is time for the government in India and the private sector to develop and implement a clear cross-sectoral approach to combat TB keeping the patient’s rights and their well-being at the centre of plans. Read the op-ed here.
February 18, 2016